13 days ago
MRK
AnalystsEmily FieldEmily Field's Stock Forecasts
AnalystsEmily Field
Sectors:
Industries:
Analyst Ranking
Top 47%
#2405 out of 5209 analysts
Average Return
+5.46%
Win Rate
67%4 out of 6
Risk vs Reward
Poor
Good
Emily Field's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Argenx SeARGX | +27.02% | $295.58 | $375.44 | 2021-10-18 - 2022-10-18 | Strong Buy |
Abbvie IncABBV | +5.06% | $224.81 | $236.19 | 2026-02-19 - 2026-03-04 | Strong Buy |
Bristol Myers Squibb CoBMY | +2.75% | $60.66 | $62.33 | 2026-02-19 - 2026-03-04 | Strong Buy |
Pfizer IncPFE | +0.11% | $26.65 | $26.62 | 2026-02-19 - 2026-03-04 | Strong Sell |
Emily Field Analyst Color
Get additional color on Emily Field's coverage of popular stocks
13 days ago
LLY
Emily Field's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pfizer IncPFE | 1 | Strong Sell | $25.00 | -6.09% | Initiates Coverage On | 13 days ago |
Merck & Co IncMRK | 1 | Strong Buy | $140.00 | +16.40% | Initiates Coverage On | 13 days ago |
Gilead Sciences IncGILD | 1 | Hold | $155.00 | +4.57% | Initiates Coverage On | 13 days ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $1,350.00 | +34.52% | Initiates Coverage On | 13 days ago |
Bristol Myers Squibb CoBMY | 1 | Strong Buy | $75.00 | +20.33% | Initiates Coverage On | 13 days ago |
Biogen IncBIIB | 1 | Hold | $185.00 | -2.60% | Initiates Coverage On | 13 days ago |
Amgen IncAMGN | 1 | Hold | $350.00 | -7.72% | Initiates Coverage On | 13 days ago |
Abbvie IncABBV | 1 | Strong Buy | $275.00 | +16.43% | Initiates Coverage On | 13 days ago |
Argenx SeARGX | 1 | Strong Buy | N/A | N/A | Upgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.